Voyager Therapeutics (VYGR) Operating Expenses (2014 - 2026)
Voyager Therapeutics (VYGR) posted Operating Expenses of $32.9 million for Q1 2026, down 27.4% sequentially from $45.3 million in Q4 2025, and down 20.17% YoY from $41.2 million in Q1 2025.
Voyager Therapeutics (VYGR) Operating Expenses (2014 - 2026) Analysis & Trends
Voyager Therapeutics has reported Operating Expenses for 13 years, with the latest figure at $32.9 million in Q1 2026.
- Quarterly Operating Expenses fell 20.17% year-over-year to $32.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $163.9 million (down 2.87% YoY) and the FY2025 annual result came in at $172.2 million, up 5.47% from the prior year.
- Operating Expenses fell to $32.9 million in Q1 2026 per VYGR's latest filing, from $45.3 million in the prior quarter.
- Over five years, Operating Expenses peaked at $45.3 million in Q4 2025 and troughed at $20.1 million in Q2 2022.
- A 5-year average of $34.6 million and a median of $35.7 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses plunged 32.94% in 2022, then jumped 56.42% in 2023.
- Over 5 years, Operating Expenses stood at $23.0 million in 2022, then surged by 56.42% to $36.0 million in 2023, then gained by 23.83% to $44.6 million in 2024, then grew by 1.55% to $45.3 million in 2025, then retreated by 27.4% to $32.9 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $32.9 million, $45.3 million, and $44.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 541.02 Mn |
| 10 | Voyager Therapeutics | 205.56 Mn | 89.22 Mn | - | 29.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.56 Mn |
| Mar 31, 2026 | 32.86 Mn |
| Dec 31, 2025 | 45.27 Mn |
| Sep 30, 2025 | 43.96 Mn |
| Jun 30, 2025 | 41.83 Mn |
| Mar 31, 2025 | 41.17 Mn |
| Dec 31, 2024 | 44.58 Mn |
| Sep 30, 2024 | 38.41 Mn |
| Jun 30, 2024 | 44.60 Mn |
| Mar 31, 2024 | 35.70 Mn |
| Dec 31, 2023 | 36.00 Mn |
| Sep 30, 2023 | 34.12 Mn |
| Jun 30, 2023 | 30.28 Mn |
| Mar 31, 2023 | 27.60 Mn |
| Dec 31, 2022 | 23.01 Mn |
| Sep 30, 2022 | 26.64 Mn |
| Jun 30, 2022 | 20.08 Mn |
| Mar 31, 2022 | 22.01 Mn |
| Dec 31, 2021 | 22.37 Mn |
| Sep 30, 2021 | 26.63 Mn |